To study effect Haridra and Madhu lepa with povidone iodine on wound healing

Comparative study of Haridra and Madhu lepa with Povidone iodine in Episiotomy wound healing

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021304

Enrollment

200

Registered

2019-09-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Haridra madhu lepa: Mode- local application Duration- 7 days Dose- 10 gms for 7 days Frequency- 6 hour interval time and after every micturation and defecation Control Intervention1: Po

Eligibility

Inclusion criteria

Inclusion criteria: Patient with vaginal delivery with episiotomy will be selected Patient of any parity will be included

Exclusion criteria

Exclusion criteria: Perineal tear Blood coagulopathy Severe vulval edema due to preeclampsia Immunocompromised patient Patient with fever local sepsis and systemic disease Dm Systemic disease like HTN Fungal infection

Design outcomes

Primary

Measure	Time frame
To Study the efficacy of Haridra and Madhu lepa on Episiotomy wound. Timepoint: 8 days	—

Secondary

Measure	Time frame
Adverse effects of the drug will be notedTimepoint: 7 days	—

Countries

India

Contacts

Public ContactDr kalpana B ayare

Saneguruji aarogya Kendra

drkalpanaayare@gmail.com9423295630

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026